{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:56:11Z","timestamp":1789095371867,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,16]],"date-time":"2015-05-16T00:00:00Z","timestamp":1431734400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00262-015-1702-8","type":"journal-article","created":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T10:11:28Z","timestamp":1431684688000},"page":"1033-1046","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice"],"prefix":"10.1007","volume":"64","author":[{"given":"Laura","family":"Jeanbart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iraklis C.","family":"Kourtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 J.","family":"van der Vlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody A.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Hubbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,16]]},"reference":[{"issue":"4","key":"1702_CR1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrc3237","volume":"12","author":"M Vanneman","year":"2012","unstructured":"Vanneman M, Dranoff G (2012) Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 12(4):237\u2013251. doi: 10.1038\/nrc3237","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1702_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39(1):1\u201310. doi: 10.1016\/j.immuni.2013.07.012","journal-title":"Immunity"},{"issue":"2","key":"1702_CR3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.molonc.2012.01.002","volume":"6","author":"TF Gajewski","year":"2012","unstructured":"Gajewski TF (2012) Cancer immunotherapy. Mol Oncol 6(2):242\u2013250. doi: 10.1016\/j.molonc.2012.01.002","journal-title":"Mol Oncol"},{"issue":"1","key":"1702_CR4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","volume":"39","author":"K Palucka","year":"2013","unstructured":"Palucka K, Banchereau J (2013) Dendritic-cell-based therapeutic cancer vaccines. Immunity 39(1):38\u201348. doi: 10.1016\/j.immuni.2013.07.004","journal-title":"Immunity"},{"issue":"4","key":"1702_CR5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","volume":"12","author":"NP Restifo","year":"2012","unstructured":"Restifo NP, Dudley ME, Rosenberg SA (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12(4):269\u2013281. doi: 10.1038\/nri3191","journal-title":"Nat Rev Immunol"},{"issue":"7378","key":"1702_CR6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","volume":"480","author":"I Mellman","year":"2011","unstructured":"Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480(7378):480\u2013489. doi: 10.1038\/nature10673","journal-title":"Nature"},{"key":"1702_CR7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nrc3153","volume":"11","author":"P Sharma","year":"2011","unstructured":"Sharma P, Wagner K, Wolchok JD, Allison JP (2011) Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat Rev Cancer 11:805\u2013812. doi: 10.1038\/nrc3153","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1702_CR8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri1936","volume":"6","author":"L Zitvogel","year":"2006","unstructured":"Zitvogel L, Tesniere A, Kroemer G (2006) Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 6(10):715\u2013727. doi: 10.1038\/nri1936","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1702_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.immuni.2013.07.005","volume":"39","author":"GT Motz","year":"2013","unstructured":"Motz GT, Coukos G (2013) Deciphering and reversing tumor immune suppression. Immunity 39(1):61\u201373. doi: 10.1016\/j.immuni.2013.07.005","journal-title":"Immunity"},{"issue":"15","key":"1702_CR10","first-page":"4441","volume":"63","author":"S Kusmartsev","year":"2003","unstructured":"Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R, Gabrilovich D (2003) All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res 63(15):4441\u20134449","journal-title":"Cancer Res"},{"issue":"6","key":"1702_CR11","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1158\/1078-0432.CCR-09-3272","volume":"16","author":"S Nagaraj","year":"2010","unstructured":"Nagaraj S, Youn JI, Weber H, Iclozan C, Lu L, Cotter MJ, Meyer C, Becerra CR, Fishman M, Antonia S, Sporn MB, Liby KT, Rawal B, Lee JH, Gabrilovich DI (2010) Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. Clin Cancer Res 16(6):1812\u20131823. doi: 10.1158\/1078-0432.CCR-09-3272","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1702_CR12","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/0008-5472.CAN-06-2925","volume":"67","author":"D Hou","year":"2007","unstructured":"Hou D, Muller A, Sharma M, DuHadaway J, Banerjee T, Johnson M, Mellor A, Prendergast G, Munn D (2007) Inhibition of indoleamine 2, 3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res 67(2):792\u2013801. doi: 10.1158\/0008-5472.CAN-06-2925","journal-title":"Cancer Res"},{"issue":"12","key":"1702_CR13","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1002\/eji.201041093","volume":"40","author":"X Li","year":"2010","unstructured":"Li X, Kostareli E, Suffner J, Garbi N, H\u00e4mmerling GJ (2010) Efficient Treg depletion induces T-cell infiltration and rejection of large tumors. Eur J Immunol 40(12):3325\u20133335. doi: 10.1002\/eji.201041093","journal-title":"Eur J Immunol"},{"issue":"6","key":"1702_CR14","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1172\/JCI64859","volume":"123","author":"A Marabelle","year":"2013","unstructured":"Marabelle A, Kohrt H, Sagiv-Barfi I, Ajami B, Axtell RC, Zhou G, Rajapaksa R, Green MR, Torchia J, Brody J, Luong R, Rosenblum MD, Steinman L, Levitsky HI, Tse V, Levy R (2013) Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. J Clin Invest 123(6):2447\u20132463. doi: 10.1172\/JCI64859DS1","journal-title":"J Clin Invest"},{"issue":"13","key":"1702_CR15","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1158\/0008-5472.CAN-13-3596","volume":"74","author":"ZC Ding","year":"2014","unstructured":"Ding ZC, Lu X, Yu M, Lemos H, Huang L, Chandler P, Liu K, Walters M, Krasinski A, Mack M, Blazar BR, Mellor AL, Munn DH, Zhou G (2014) Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1\u2013PD-L1 axis. Cancer Res 74(13):3441\u20133453. doi: 10.1158\/0008-5472.CAN-13-3596","journal-title":"Cancer Res"},{"issue":"8","key":"1702_CR16","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","volume":"111","author":"K Movahedi","year":"2008","unstructured":"Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111(8):4233\u20134244. doi: 10.1182\/blood-2007-07-099226","journal-title":"Blood"},{"issue":"4","key":"1702_CR17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12(4):253\u2013268. doi: 10.1038\/nri3175","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1702_CR18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"D Gabrilovich","year":"2009","unstructured":"Gabrilovich D, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3):162\u2013174. doi: 10.1038\/nri2506","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1702_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","volume":"32","author":"T Condamine","year":"2011","unstructured":"Condamine T, Gabrilovich DI (2011) Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol 32(1):19\u201325. doi: 10.1016\/j.it.2010.10.002","journal-title":"Trends Immunol"},{"issue":"2","key":"1702_CR20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coi.2010.01.021","volume":"22","author":"E Peranzoni","year":"2010","unstructured":"Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 22(2):238\u2013244. doi: 10.1016\/j.coi.2010.01.021","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"1702_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semcancer.2005.07.005","volume":"16","author":"P Serafini","year":"2006","unstructured":"Serafini P, Borrello I, Bronte V (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 16(1):53\u201365. doi: 10.1016\/j.semcancer.2005.07.005","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1702_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.1300654","volume":"191","author":"S Nagaraj","year":"2013","unstructured":"Nagaraj S, Youn JI, Gabrilovich DI (2013) Reciprocal relationship between myeloid-derived suppressor cells and T cells. J Immunol 191(1):17\u201323. doi: 10.4049\/jimmunol.1300654","journal-title":"J Immunol"},{"issue":"1","key":"1702_CR23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1189\/jlb.0111021","volume":"90","author":"S Solito","year":"2011","unstructured":"Solito S, Bronte V, Mandruzzato S (2011) Antigen specificity of immune suppression by myeloid-derived suppressor cells. J Leukoc Biol 90(1):31\u201336. doi: 10.1189\/jlb.0111021","journal-title":"J Leukoc Biol"},{"issue":"3","key":"1702_CR24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.celrep.2012.08.006","volume":"2","author":"S Ugel","year":"2012","unstructured":"Ugel S, Peranzoni E, Desantis G, Chioda M, Walter S, Weinschenk T, Ochando JC, Cabrelle A, Mandruzzato S, Bronte V (2012) Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. Cell Rep 2(3):628\u2013639. doi: 10.1016\/j.celrep.2012.08.006","journal-title":"Cell Rep"},{"issue":"3","key":"1702_CR25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ni.2539","volume":"14","author":"TA Wynn","year":"2013","unstructured":"Wynn TA (2013) Myeloid-cell differentiation redefined in cancer. Nat Immunol 14(3):197\u2013199. doi: 10.1038\/ni.2539","journal-title":"Nat Immunol"},{"issue":"5","key":"1702_CR26","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.4049\/jimmunol.181.5.3291","volume":"181","author":"S Watanabe","year":"2008","unstructured":"Watanabe S, Deguchi K, Zheng R, Tamai H, Wang L-X, Cohen PA, Shu S (2008) Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J Immunol 181(5):3291\u20133300. doi: 10.4049\/jimmunol.181.5.3291","journal-title":"J Immunol"},{"key":"1702_CR27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fonc.2013.00049","volume":"3","author":"YG Najjar","year":"2013","unstructured":"Najjar YG, Finke JH (2013) Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer. Front Oncol 3:49. doi: 10.3389\/fonc.2013.00049","journal-title":"Front Oncol"},{"issue":"7","key":"1702_CR28","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1158\/1078-0432.CCR-11-0024","volume":"17","author":"MG Lechner","year":"2011","unstructured":"Lechner MG, Epstein AL (2011) A new mechanism for blocking myeloid-derived suppressor cells by CpG. Clin Cancer Res 17(7):1645\u20131648. doi: 10.1158\/1078-0432.CCR-11-0024","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1702_CR29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","volume":"11","author":"C Shi","year":"2011","unstructured":"Shi C, Pamer EG (2011) Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11(11):762\u2013774. doi: 10.1038\/nri3070","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"1702_CR30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.1989","volume":"29","author":"F Leuschner","year":"2011","unstructured":"Leuschner F, Dutta P, Gorbatov R, Novobrantseva TI, Donahoe JS, Courties G, Lee KM, Kim JI, Markmann JF, Marinelli B, Panizzi P, Lee WW, Iwamoto Y, Milstein S, Epstein-Barash H, Cantley W, Wong J, Cortez-Retamozo V, Newton A, Love K, Libby P, Pittet MJ, Swirski FK, Koteliansky V, Langer R, Anderson DG, Weissleder R, Nahrendorf M (2011) Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol 29(11):1005\u20131010. doi: 10.1038\/nbt.1989","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1702_CR31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2013.08.055","volume":"155","author":"B Chanda","year":"2013","unstructured":"Chanda B, Ditadi A, Iscove NN, Keller G (2013) Retinoic acid signaling is essential for embryonic hematopoietic stem cell development. Cell 155(1):215\u2013227. doi: 10.1016\/j.cell.2013.08.055","journal-title":"Cell"},{"issue":"18","key":"1702_CR32","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1158\/0008-5472.CAN-06-1690","volume":"66","author":"N Mirza","year":"2006","unstructured":"Mirza N, Fishman M, Fricke I, Dunn M, Neuger A, Frost T, Lush R, Antonia S, Gabrilovich D (2006) All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res 66(18):9299\u20139307. doi: 10.1158\/0008-5472.CAN-06-1690","journal-title":"Cancer Res"},{"issue":"22","key":"1702_CR33","doi-asserted-by":"crossref","first-page":"11021","DOI":"10.1158\/0008-5472.CAN-07-2593","volume":"67","author":"Y Nefedova","year":"2007","unstructured":"Nefedova Y, Fishman M, Sherman S, Wang X, Beg A, Gabrilovich D (2007) Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Res 67(22):11021\u201311028. doi: 10.1158\/0008-5472.CAN-07-2593","journal-title":"Cancer Res"},{"issue":"7\u20138","key":"1702_CR34","first-page":"900","volume":"9","author":"HK Le","year":"2009","unstructured":"Le HK, Graham L, Cha E, Morales JK, Manjili MH, Bear HD (2009) Gemcitabine directly inhibits myeloid derived suppressor cells in BALB\/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Int Immunopharmacol 9(7\u20138):900\u2013909. doi: 10.1016\/j.intimp.2009.03.015","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"1702_CR35","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/0008-5472.CAN-09-3690","volume":"70","author":"J Vincent","year":"2010","unstructured":"Vincent J, Mignot G, Chalmin F, Ladoire S, Bruchard M, Chevriaux A, Martin F, Apetoh L, Rebe C, Ghiringhelli F (2010) 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. Cancer Res 70(8):3052\u20133061. doi: 10.1158\/0008-5472.CAN-09-3690","journal-title":"Cancer Res"},{"issue":"7","key":"1702_CR36","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1078-0432.CCR-10-2672","volume":"17","author":"C Zoglmeier","year":"2011","unstructured":"Zoglmeier C, Bauer H, Norenberg D, Wedekind G, Bittner P, Sandholzer N, Rapp M, Anz D, Endres S, Bourquin C (2011) CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice. Clin Cancer Res 17(7):1765\u20131775. doi: 10.1158\/1078-0432.CCR-10-2672","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1702_CR37","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.4049\/jimmunol.1101304","volume":"188","author":"Y Shirota","year":"2012","unstructured":"Shirota Y, Shirota H, Klinman DM (2012) Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells. J Immunol 188(4):1592\u20131599. doi: 10.4049\/jimmunol.1101304","journal-title":"J Immunol"},{"issue":"1","key":"1702_CR38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/0008-5472.CAN-13-1545","volume":"74","author":"D Alizadeh","year":"2013","unstructured":"Alizadeh D, Trad M, Hanke NT, Larmonier CB, Janikashvili N, Bonnotte B, Katsanis E, Larmonier N (2013) Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T cell transfer in breast cancer. Cancer Res 74(1):104\u2013118. doi: 10.1158\/0008-5472.CAN-13-1545","journal-title":"Cancer Res"},{"issue":"11","key":"1702_CR39","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.4049\/jimmunol.1200274","volume":"189","author":"KN Kodumudi","year":"2012","unstructured":"Kodumudi KN, Weber A, Sarnaik AA, Pilon-Thomas S (2012) Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma. J Immunol 189(11):5147\u20135154. doi: 10.4049\/jimmunol.1200274","journal-title":"J Immunol"},{"issue":"7","key":"1702_CR40","doi-asserted-by":"crossref","first-page":"e40677","DOI":"10.1371\/journal.pone.0040677","volume":"7","author":"MK Srivastava","year":"2012","unstructured":"Srivastava MK, Zhu L, Harris-White M, Kar U, Huang M, Johnson MF, Lee JM, Elashoff D, Strieter R, Dubinett S, Sharma S (2012) Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS One 7(7):e40677. doi: 10.1371\/journal.pone.0040677.t001","journal-title":"PLoS One"},{"issue":"1","key":"1702_CR41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1158\/0008-5472.CAN-13-1816","volume":"74","author":"S Mok","year":"2014","unstructured":"Mok S, Koya RC, Tsui C, Xu J, Robert L, Wu L, Graeber TG, West BL, Bollag G, Ribas A (2014) Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy. Cancer Res 74(1):153\u2013161. doi: 10.1158\/0008-5472.CAN-13-1816","journal-title":"Cancer Res"},{"issue":"1","key":"1702_CR42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrc2292","volume":"8","author":"P Karran","year":"2008","unstructured":"Karran P, Attard N (2008) Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer 8(1):24\u201336. doi: 10.1038\/nrc2292","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1702_CR43","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-3565(24)36860-0","volume":"282","author":"J Aubrecht","year":"1997","unstructured":"Aubrecht J, Goad ME, Schiestl RH (1997) Tissue specific toxicities of the anticancer drug 6-thioguanine is dependent on the Hprt status in transgenic mice. J Pharmacol Exp Ther 282(2):1102\u20131108","journal-title":"J Pharmacol Exp Ther"},{"key":"1702_CR44","first-page":"1627","volume":"31","author":"GA LePage","year":"1971","unstructured":"LePage GA, Whitecar JPJ (1971) Pharmacology of 6-thioguanine in Man. Cancer Res 31:1627\u20131631","journal-title":"Cancer Res"},{"issue":"15","key":"1702_CR45","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","volume":"349","author":"JM Goldman","year":"2003","unstructured":"Goldman JM, Melo JV (2003) Chronic myeloid leukemia\u2014advances in biology and new approaches to treatment. N Engl J Med 349(15):1451\u20131464. doi: 10.1056\/NEJMra020777","journal-title":"N Engl J Med"},{"issue":"1","key":"1702_CR46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","volume":"112","author":"S Reddy","year":"2006","unstructured":"Reddy S, Rehor A, Schmoekel H, Hubbell J, Swartz M (2006) In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release 112(1):26\u201334. doi: 10.1016\/j.jconrel.2006.01.006","journal-title":"J Control Release"},{"issue":"4","key":"1702_CR47","doi-asserted-by":"crossref","first-page":"e61646","DOI":"10.1371\/journal.pone.0061646","volume":"8","author":"IC Kourtis","year":"2013","unstructured":"Kourtis IC, Hirosue S, de Titta A, Kontos S, Stegmann T, Hubbell JA, Swartz MA (2013) Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice. PLoS One 8(4):e61646. doi: 10.1371\/journal.pone.0061646.s006","journal-title":"PLoS One"},{"issue":"10","key":"1702_CR48","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1021\/mp3001183","volume":"9","author":"AJ Vlies van der","year":"2012","unstructured":"van der Vlies AJ, Hasegawa U, Hubbell JA (2012) Reduction-sensitive tioguanine prodrug micelles. Mol Pharm 9(10):2812\u20132818. doi: 10.1021\/mp3001183","journal-title":"Mol Pharm"},{"issue":"4","key":"1702_CR49","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1021\/bc9004443","volume":"21","author":"AJ Vlies van der","year":"2010","unstructured":"van der Vlies AJ, O\u2019neil CP, Hasegawa U, Hammond N, Hubbell JA (2010) Synthesis of pyridyl disulfide-functionalized nanoparticles for conjugating thiol-containing small molecules, peptides, and proteins. Bioconjug Chem 21(4):653\u2013662. doi: 10.1021\/bc9004443","journal-title":"Bioconjug Chem"},{"issue":"5","key":"1702_CR50","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2326-6066.CIR-14-0019-T","volume":"2","author":"L Jeanbart","year":"2014","unstructured":"Jeanbart L, Ballester M, de Titta A, Corthesy P, Romero P, Hubbell JA, Swartz MA (2014) Enhancing efficacy of anti-cancer vaccines by targeted delivery to tumor-draining lymph nodes. Cancer Immunol Res 2(5):436\u2013447. doi: 10.1158\/2326-6066.CIR-14-0019-T","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"1702_CR51","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","volume":"32","author":"I Marigo","year":"2010","unstructured":"Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, Dolcetti L, Ugel S, Sonda N, Bicciato S, Falisi E, Calabrese F, Basso G, Zanovello P, Cozzi E, Mandruzzato S, Bronte V (2010) Tumor-induced tolerance and immune suppression depend on the C\/EBP\u03b2 transcription factor. Immunity 32(6):790\u2013802. doi: 10.1016\/j.immuni.2010.05.010","journal-title":"Immunity"},{"key":"1702_CR52","first-page":"1","volume":"20","author":"WW Overwijk","year":"2001","unstructured":"Overwijk WW, Restifo NP (2001) B16 as a mouse model for human melanoma. Curr Protoc Immunol Chapter 20:1\u201329. doi: 10.1002\/0471142735.im2001s39","journal-title":"Curr Protoc Immunol Chapter"},{"issue":"148","key":"1702_CR53","doi-asserted-by":"crossref","first-page":"148rv149","DOI":"10.1126\/scitranslmed.3003763","volume":"4","author":"MA Swartz","year":"2012","unstructured":"Swartz MA, Hirosue S, Hubbell JA (2012) Engineering approaches to immunotherapy. Sci Transl Med 4(148):148rv149. doi: 10.1126\/scitranslmed.3003763","journal-title":"Sci Transl Med"},{"issue":"11","key":"1702_CR54","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nmat3775","volume":"12","author":"DJ Irvine","year":"2013","unstructured":"Irvine DJ, Swartz MA, Szeto GL (2013) Engineering synthetic vaccines using cues from natural immunity. Nat Mater 12(11):978\u2013990. doi: 10.1038\/nmat3775","journal-title":"Nat Mater"},{"issue":"8","key":"1702_CR55","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","volume":"181","author":"J-I Youn","year":"2008","unstructured":"Youn J-I, Nagaraj S, Collazo M, Gabrilovich DI (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 181(8):5791\u20135802. doi: 10.4049\/jimmunol.181.8.5791","journal-title":"J Immunol"},{"issue":"3","key":"1702_CR56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ni.2526","volume":"14","author":"J-I Youn","year":"2013","unstructured":"Youn J-I, Kumar V, Collazo M, Nefedova Y, Condamine T, Cheng P, Villagra A, Antonia S, McCaffrey JC, Fishman M, Sarnaik A, Horna P, Sotomayor E, Gabrilovich DI (2013) Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat Immunol 14(3):211\u2013220. doi: 10.1038\/ni.2526","journal-title":"Nat Immunol"},{"issue":"1","key":"1702_CR57","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/1471-2407-10-464","volume":"10","author":"JD Veltman","year":"2010","unstructured":"Veltman JD, Lambers ME, van Nimwegen M, Hendriks RW, Hoogsteden HC, Aerts JG, Hegmans JP (2010) COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function. BMC Cancer 10(1):464. doi: 10.1186\/1471-2407-10-464","journal-title":"BMC Cancer"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-015-1702-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1702-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1702-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:16:21Z","timestamp":1748391381000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-015-1702-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,16]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1702"],"URL":"https:\/\/doi.org\/10.1007\/s00262-015-1702-8","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,16]]}}}